Nebulized Interferon Beta-1a Promising for COVID-19

TUESDAY, Nov. 17, 2020 -- Patients hospitalized with COVID-19 who receive inhaled nebulized interferon beta-1a (SNG001) have greater odds of improvement than those receiving placebo, according to a study published online Nov. 12 in The Lancet...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news